Related Experiment Video

Updated: Jun 12, 2026

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

G-CSF increases mesenchymal precursor cell numbers in the bone marrow via an indirect mechanism involving

Nathalie Brouard1, Rebecca Driessen, Brenton Short

  • 1Center for Stem Cell Research, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, 1825 Pressler Street, Houston, TX 77030, USA. Nathalie.Brouard@uth.tmc.edu

Stem Cell Research
|June 12, 2010
PubMed

Insights

Granulocyte-colony stimulating factor (G-CSF) increases myeloid progenitor cells (MPC) in bone marrow, not circulation. This expansion is linked to G-CSF-induced bone resorption, offering potential for clinical applications.

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Bone Biology

Background:

  • Granulocyte-colony stimulating factor (G-CSF) is widely used for hematopoietic stem cell mobilization.
  • The effect of G-CSF on myeloid progenitor cells (MPC) in circulation and bone marrow remains incompletely understood.

Purpose of the Study:

  • To investigate whether G-CSF influences the number of MPC in circulation and bone marrow.
  • To elucidate the mechanism behind G-CSF-induced changes in MPC numbers.

Main Methods:

  • Assessed fibroblast colony-forming cells (CFU-F) in vitro to quantify MPC.
  • Administered G-CSF to mice and analyzed bone marrow (BM) and blood.
  • Utilized hydroxyurea to assess CFU-F proliferation.
  • Administered osteoprotegerin (OPG), an osteoclast inhibitor, to investigate the role of bone resorption.

Main Results:

  • G-CSF did not increase circulating MPC (CFU-F) but significantly increased BM CFU-F in a time-dependent manner, peaking at Day 7.
  • Hydroxyurea treatment did not affect CFU-F numbers, indicating proliferation is not the primary mechanism for expansion.
  • OPG administration blocked the G-CSF-induced increase in BM CFU-F, supporting the role of bone resorption.

Conclusions:

  • G-CSF administration leads to an expansion of MPC within the bone marrow, not in circulation.
  • This expansion is mediated by G-CSF-induced bone resorption.
  • G-CSF's ability to expand MPC in vivo presents a potential clinical strategy for cell expansion.

More Related Videos

Real-Time Imaging of CCL5-Induced Migration of Periosteal Skeletal Stem Cells in Mice06:10

Real-Time Imaging of CCL5-Induced Migration of Periosteal Skeletal Stem Cells in Mice

Published on: September 16, 2020

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.